Inhibitory influence of oxytocin infusion on contingent negative variation and some memory tasks in normal men
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ader, 1972, Effects of lysine vasopression on passive avoidance learning, Psychon Sci, 29, 46, 10.3758/BF03336564
Ansseau, 1984, Self-reports of anxiety level and EEG changes after a single dose of benzodiazepine, Neuropsychobiology, 12, 255, 10.1159/000118148
Ansseau, 1987, Intranasal oxytocin in obsessive-compulsive disorder: a case report, Psychoneuroendocrinology, 12, 231, 10.1016/0306-4530(87)90009-6
Beckwith, 1982, Vasopressin analog (DDAVP) facilitates concept learning in human males, Peptides, 3, 627, 10.1016/0196-9781(82)90162-0
Beckwith, 1983, Vasopressin analog influences the performance of males in a reaction time task, Peptides, 4, 707, 10.1016/0196-9781(83)90022-0
Bohus, 1972, Effects of vasopressin on active and passive avoidance behavior, Horm Behav, 3, 191, 10.1016/0018-506X(72)90031-1
Bohus, 1978, Opposite effects of oxytocin and arginine vasopressin on avoidance behavior and hippocampal theta rhythm in the rat, Neuropharmacology, 17, 239, 10.1016/0028-3908(78)90107-7
Bohus, 1978, Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes, Brain Res, 157, 414, 10.1016/0006-8993(78)90052-5
de Wied, 1971, Long term effects of vasopressin on the maintenance of a conditioned avoidance response in the rat, Nature, 232, 58, 10.1038/232058a0
de Wied, 1979, Neurohypophyseal principles and memory, Fed Proc, 38, 2348
Fehm-Wolfsdorf, 1984, Human memory and neurohypophyseal hormones: opposite effects of vasopressin and oxytocin, Psychoneuroendocrinology, 9, 289, 10.1016/0306-4530(84)90007-6
Ferrier, 1980, Influence of oxytocin on human memory processes, Life Sci, 27, 2311, 10.1016/0024-3205(80)90499-3
Gabor, 1979, Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic midbrain structures, Brain Res, 175, 303, 10.1016/0006-8993(79)91009-6
Gold, 1979, Effects of 1-desamino-D-arginine vasopressin on behaviour and cognition in primary affective disorder, Lancett, ii, 992, 10.1016/S0140-6736(79)92563-7
Hostetter, 1977, Vasopressin affects the behaviour of rats in a positively-rewarded discrimination task, Life Sci, 21, 1321, 10.1016/0024-3205(77)90014-5
Jenkins, 1982, Effect of desmopressin on normal and impaired memory, J. Neurol Neurosurg Psychiat, 45, 830, 10.1136/jnnp.45.9.830
Kennett, 1982, Influence of oxytocin an human memory processes: validation by a control study, Life Sci, 31, 273, 10.1016/0024-3205(82)90589-6
Kovacs, 1978, Opposite action of oxytocin to vasopressin in passive avoidance behavior, Physiol Behav, 20, 801, 10.1016/0031-9384(78)90309-8
Kovacs, 1983, Effects of oxytocin, desglycinamide oxytocin and anti-oxytocin serum on the alpha-MPT-induced disappearance of catecholamines in the rat brain, Brain Res, 268, 307, 10.1016/0006-8993(83)90497-3
Laczi, 1982, Effects of lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients, Psychoneuroendocrinology, 7, 185, 10.1016/0306-4530(82)90011-7
Laczi, 1983, Effects of desglycinamide-arginine-vasopressin (DGAVP) on memory processes in diabetes insipidus patients and non-diabetic subjects, Acta Endocrinol, 102, 205, 10.1530/acta.0.1020205
Legros, 1978, Influence of vasopressin on learning and memory, Lancet, i, 41, 10.1016/S0140-6736(78)90386-0
Marczynski, 1978, Neurochemical mechanisms in the genesis of slow potentials: a review and some clinical applications, 25
McCallum, 1979, Cognitive aspects of slow potential changes, 151
Muhlethaler, 1983, Characterization of a uterine-type oxytocin receptor in the rat hippocampus, 80, 6713
Nebes, 1984, The effect of vasopressin on memory in the healthy elderly, Psychiatry Res, 11, 49, 10.1016/0165-1781(84)90107-0
Peabody, 1985, Desglycinamide-9-arginine-8-vasopressin (DGAVP, Organon 5667) in patients with dementia, Neurobiol Aging, 6, 95, 10.1016/0197-4580(85)90024-7
Rebert, 1980, Neurobehavioral aspects of brain slow potentials, Progr Brain Res, 54, 381, 10.1016/S0079-6123(08)61650-7
Rey, 1966
Schulz, 1974, Effect of physiological doses of vasopressin and oxytocin on avoidance behaviour and explaratory behaviour in rats, Acta Physiol Acad Sci Hung, 45, 211
Skinner, 1977, Central gating mechanism that regulate event-related potentials and behaviour. A neural model for attention, Prog Clin Neurophysiol, 1, 30
Skinner, 1980, Electrogenesis of event-related slow potentials in the cerebral cortex of conscious animals, 21
Squires, 1983, Human endogenous limbic potentials: cross modality and depth/surface components in epileptic subjects, Adv Psychol, 16, 217, 10.1016/S0166-4115(08)62041-5
Stuss, 1986
Telegdy, 1979, Role of monoamines in mediating the action of ACTH, vasopressin and oxytocin, 189
Timsit-Berthier, 1984, Variation contingente négative et composantes endogènes du potentiel évoqué, Rev EEG Neuroophysiol, 14, 77
Timsit-Berthier, 1981, CNV and functional state changes during longlasting and repetitive recording sessions, Progr Brain: Res, 54, 673, 10.1016/S0079-6123(08)61689-1
Timsit-Berthier, 1982, Action of lysine vasopressin on human electrophysiological activity: night sleep pattern, auditory evoked potential, contingent negative variation, Neuropsychobiology, 8, 248, 10.1159/000117906
Van Heuven-Nolsen, 1984, Oxytocin affects utilisation of noradrenaline in distinct limbic-forebrain regions of the rat brain, Neuropharmacology, 23, 1373, 10.1016/0028-3908(84)90075-3
Van Wimersma Greidanus, 1976, Dorsal hippocampus: a site of opposite action of neuropeptides on avoidance behaviour, Pharmacol Biochem Behav, 5, 29, 10.1016/0091-3057(76)90325-7
Van Wimersma Greidanus, 1975, Intravenous administration of anti-vasopressin serum inhibits memory consolidation in rats, Life Sci, 16, 637, 10.1016/S0024-3205(75)80015-4
Vranckx, 1979, Vasopressin and schizophrenia, 753
Walter, 1964, Contingent negative variation: an electrical sign of sensori-motor association and expectancy in the human brain, Nature, 203, 380, 10.1038/203380a0
Weingartner, 1981, Vasopressin treatment of cognitive dysfunction in progressive dementia, Life Sci, 29, 2721, 10.1016/0024-3205(81)90531-2